You are here

Oral Micronized Progesterone for Perimenopausal Hot Flushes

CeMCOR is now recruiting participants for this CIHR-funded randomized controlled trial to test whether oral micronized progesterone is more effective than placebo as therapy for hot flushes and night sweats in perimenopausal women.

The study is open to perimenopausal women 35 to 58 (who have menstruated within the past 12 months) with moderate-to-severe hot flushes (4 per day) and/or night sweats (waking twice weekly). Participants should not have used estrogen, progesterone, progestin or hormonal birth control within the past 6 months.

To obtain more details about your eligibility click here or call or e-mail study coordinator Andrea Cameron at the contact below.

Phone: (604)875-5960
Toll free: 1 855 875-5960
E-mail: andrea.cameron@ubc.ca

 

Join a Study:

Enrolment complete: Perimenopausal Hot Flush Study

Enrolment is now complete. Thank you for your interest.
CeMCOR is now recruiting Canadian women for this CIHR-funded randomized controlled trial to test whether oral micronized progesterone is more effective than placebo as therapy for hot flushes and night sweats in perimenopausal women.

LEARN MORE

 

Get Involved

Volunteer research participants are the heart of all CeMCOR research. Participants are invited to provide feedback on study processes, to learn their own results and at the end of a study, be the first to hear what the whole study found. Please become a CeMCOR research participant—you can contribute to improving the scientific information available for daughters, friends and the wider world of women.